Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.60 |
| ▸ | STK17B | O94768 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.43 |
| ▸ | HTR1A | P08908 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Akuammicine SCHEMBL23675922 | 1.00 | MEN1 (0.69) | MEN1KMT2ATDP1OPRK1STK17B | |
| Akuammicine SCHEMBL2685206 | 1.00 | MEN1 (0.69) | MEN1KMT2ATDP1OPRK1STK17B | |
| Akuammicine SCHEMBL26667911 | 1.00 | MEN1 (0.69) | MEN1KMT2ATDP1OPRK1STK17B | |
| Vinervine SCHEMBL30046744 | 0.90 | MEN1 (0.74) | MEN1KMT2ATDP1OPRK1STK17B | |
| SCHEMBL26668918 | 0.89 | MEN1 (0.55) | MEN1KMT2ATDP1OPRK1STK17B | |
| Sewarine SCHEMBL30047246 | 0.88 | MEN1 (0.54) | MEN1KMT2ATDP1OPRK1STK17B | |
| Sewarine SCHEMBL26668717 | 0.88 | MEN1 (0.54) | MEN1KMT2ATDP1OPRK1STK17B | |
| SCHEMBL26667892 | 0.87 | MEN1 (0.53) | MEN1KMT2ATDP1OPRK1STK17B | |
| SCHEMBL26668570 | 0.87 | MEN1 (0.53) | MEN1KMT2ATDP1OPRK1STK17B | |
| SCHEMBL26668915 | 0.87 | MEN1 (0.53) | MEN1KMT2ATDP1OPRK1STK17B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132145-A1 | METHODS OF PREPARING ISOMERS, ANALOGS, AND SYNTHETIC DERIVATIVES FROM AKUAMMA SEEDS | MITCHELL HAYWOOD MAX (US) | 2026-05-14 | — | — | US | disclosed |
| CN-114245826-A | Method for producing strictoside and monoterpene indole alkaloid | 丹麦科技大学 | 2022-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132145-A1 | METHODS OF PREPARING ISOMERS, ANALOGS, AND SYNTHETIC DERIVATIVES FROM AKUAMMA SEEDS | AAK1, AURKA, KMO | MEN1 4856/4885KMT2A 301/4885TDP1 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.